Systemic therapies for inflammatory eye disease: past, present and future
about
Drug discovery in ophthalmology: past success, present challenges, and future opportunitiesHeterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitisPharmacotherapy for uveitis: current management and emerging therapy.Objective measurement of vitreous inflammation using optical coherence tomography.Immunopharmacotherapy of non-infectious uveitis: where do we stand?Automated Analysis of Vitreous Inflammation Using Spectral-Domain Optical Coherence TomographyAutoimmune uveitis: clinical, pathogenetic, and therapeutic features.Ocular inflammation and endoplasmic reticulum stress are attenuated by supplementation with grape polyphenols in human retinal pigmented epithelium cells and in C57BL/6 mice.An overview of the clinical applications of optical coherence tomography angiography.Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal.Reversible lesion involving the splenium of the corpus callosum caused by phenytoin sodium withdrawal.Optimizing OCT acquisition parameters for assessments of vitreous haze for application in uveitis.Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenon's triamcinolone acetonide for uveitic cystoid macular oedema.mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol.
P2860
Q26771638-77E67DAB-DFF2-4F7A-9182-1F3D52F60024Q26796779-B7CCAEE5-4B66-4629-B769-64F748AF81CBQ34274075-3922C52C-8409-4762-8C1F-3BD1FE425244Q35866363-E5205201-6B0F-4D72-B2BD-D83F257E679FQ35994694-A37F53BA-03D1-4F33-8B67-846290776C72Q36067976-5C9F13ED-DB8C-460B-A89A-C5851BBBCE57Q38395263-12015AF4-D7AD-491A-B811-ECB5BC1B8444Q39008193-B6AE4819-E133-46DA-854D-7B9F9D058EF3Q47958511-06B11B26-F9B1-49DC-919E-4DF3C4B29D65Q48280517-1DEC054B-9714-4E85-A5B9-90CF8A4E0C31Q48423086-5AB4AD6E-98E6-4BCC-937E-84350DB2A0E8Q49479819-095CC56E-00BB-4D22-AC71-169B1FAAFD46Q53107185-A6C1503B-0280-4C2A-B0B5-1856E1E52802Q55260506-2A5DC5B2-E50F-4C9F-B345-EE23D0EDE77C
P2860
Systemic therapies for inflammatory eye disease: past, present and future
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Systemic therapies for inflammatory eye disease: past, present and future
@ast
Systemic therapies for inflammatory eye disease: past, present and future
@en
Systemic therapies for inflammatory eye disease: past, present and future
@nl
type
label
Systemic therapies for inflammatory eye disease: past, present and future
@ast
Systemic therapies for inflammatory eye disease: past, present and future
@en
Systemic therapies for inflammatory eye disease: past, present and future
@nl
prefLabel
Systemic therapies for inflammatory eye disease: past, present and future
@ast
Systemic therapies for inflammatory eye disease: past, present and future
@en
Systemic therapies for inflammatory eye disease: past, present and future
@nl
P2860
P356
P1433
P1476
Systemic therapies for inflammatory eye disease: past, present and future
@en
P2093
Alastair K Denniston
Andrew D Dick
P2860
P2888
P356
10.1186/1471-2415-13-18
P5008
P577
2013-04-24T00:00:00Z
P5875
P6179
1011542536